(Q54125043)
Statements
Phase I and pharmacokinetic study of paclitaxel in combination with biricodar, a novel agent that reverses multidrug resistance conferred by overexpression of both MDR1 and MRP. (English)
1 reference
E K Rowinsky
1 reference
L Smith
1 reference
Y M Wang
1 reference
P Chaturvedi
1 reference
M Villalona
1 reference
E Campbell
1 reference
C Aylesworth
1 reference
S G Eckhardt
1 reference
L Hammond
1 reference
M Kraynak
1 reference
R Drengler
1 reference
J Stephenson
1 reference
M W Harding
1 reference
D D Von Hoff
1 reference
1 September 1998
1 reference
16
1 reference
2964-2976
1 reference
9
1 reference
Identifiers
1 reference